Purdue Pharma L.P. v. Accord Healthcare, Inc.

Track this case

Case Number:

23-1953

Court:

Appellate - Federal Circuit

Nature of Suit:

835 Patent - (ANDA) (Fed. Qst.)

Companies

Sectors & Industries:

  1. October 07, 2024

    Fed. Circ. Questions If Safer OxyContin Profits Came From IP

    An attorney for Purdue Pharma didn't seem to find much purchase at the Federal Circuit on Monday as he argued that the company's patents for abuse-deterrent OxyContin weren't obvious, claiming other companies had ample opportunity to reach a solution and failed to do so.

  2. September 12, 2023

    Indian Co. Urges Fed. Circ. To Back Obviousness Of Oxy IP

    Accord Healthcare Inc. has urged the Federal Circuit to uphold its win in a dispute in which bankrupt Purdue Pharma LP lost its legal effort to use patent laws to block the Indian drugmaker from launching a generic version of OxyContin.